Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56726 - 56750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	SP140L	93349	upregulated	panobinostat results in increased expression of SP140L mRNA	2q37.1	A21037
Panobinostat	Approved Investigational	SP5	389058	upregulated	panobinostat results in increased expression of SP5 mRNA	2q31.1	A21037
Panobinostat	Approved Investigational	SP6	80320	upregulated	panobinostat results in increased expression of SP6 mRNA	17q21.32	A21037
Panobinostat	Approved Investigational	SP8	221833	downregulated	panobinostat results in decreased expression of SP8 mRNA	7p21.1	A21037
Panobinostat	Approved Investigational	SPHK1	8877	upregulated	panobinostat results in increased expression of SPHK1 mRNA	17q25.2	A21037
Panobinostat	Approved Investigational	SPINK1	6690	upregulated	panobinostat results in increased expression of SPINK1 mRNA	5q32	A21037
Panobinostat	Approved Investigational	SPINK2	6691	upregulated	panobinostat results in increased expression of SPINK2 mRNA	4q12	A21037
Panobinostat	Approved Investigational	SPP1	6696	upregulated	panobinostat results in increased expression of SPP1 mRNA	4q22.1	A21037
Panobinostat	Approved Investigational	SPRY1	10252	downregulated	panobinostat results in decreased expression of SPRY1 mRNA	4q28.1	A21037
Panobinostat	Approved Investigational	SPSB4	92369	upregulated	panobinostat results in increased expression of SPSB4 mRNA	3q23	A21037
Panobinostat	Approved Investigational	SRCIN1	80725	downregulated	panobinostat results in decreased expression of SRCIN1 mRNA	17q12	A21037
Panobinostat	Approved Investigational	SSBP2	23635	downregulated	panobinostat results in decreased expression of SSBP2 mRNA	5q14.1	A21037
Panobinostat	Approved Investigational	SST	6750	upregulated	panobinostat results in increased expression of SST mRNA	3q27.3	A21037
Panobinostat	Approved Investigational	ST3GAL1	6482	upregulated	panobinostat results in increased expression of ST3GAL1 mRNA	8q24.22	A21037
Panobinostat	Approved Investigational	ST6GALNAC5	81849	downregulated	panobinostat results in decreased expression of ST6GALNAC5 mRNA	1p31.1	A21037
Panobinostat	Approved Investigational	STAT6	6778	upregulated	panobinostat results in increased expression of STAT6 mRNA	12q13	A21037
Panobinostat	Approved Investigational	STC1	6781	upregulated	panobinostat results in increased expression of STC1 mRNA	8p21.2	A21037
Panobinostat	Approved Investigational	STEAP3	55240	upregulated	panobinostat results in increased expression of STEAP3 mRNA	2q14.2	A21037
Panobinostat	Approved Investigational	STK32A	202374	downregulated	panobinostat results in decreased expression of STK32A mRNA	5q32	A21037
Panobinostat	Approved Investigational	STMN2	11075	upregulated	panobinostat results in increased expression of STMN2 mRNA	8q21.13	A21037
Panobinostat	Approved Investigational	STRA6	64220	upregulated	panobinostat results in increased expression of STRA6 mRNA	15q24.1	A21037
Panobinostat	Approved Investigational	STYK1	55359	upregulated	panobinostat results in increased expression of STYK1 mRNA	12p13.2	A21037
Panobinostat	Approved Investigational	SULT1A2	6799	upregulated	panobinostat results in increased expression of SULT1A2 mRNA	16p11.2	A21037
Panobinostat	Approved Investigational	SULT1C2	6819	upregulated	panobinostat results in increased expression of SULT1C2 mRNA	2q12.3	A21037
Panobinostat	Approved Investigational	SUSD2	56241	upregulated	panobinostat results in increased expression of SUSD2 mRNA	22q11.23	A21037

Displaying entries 56726 - 56750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability